Loading clinical trials...
Loading clinical trials...
A Multiple Arm, Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase 2 Study of Intra-Articular Administration of an Allogeneic Human Placental Tissue Particulate (PTP-001) for the Treatment of Knee Osteoarthritis
Conditions
Interventions
PTP-001
Placebo control
Locations
14
Australia
Emeritus Research Sydney
Botany, New South Wales, Australia
Genesis Research Services
Broadmeadow, New South Wales, Australia
Royal North Shore Hospital
Saint Leonards, New South Wales, Australia
Holdsworth House Medical Practice
Sydney, New South Wales, Australia
Emeritus Research Melbourne
Camberwell, Victoria, Australia
Hamilton Medical Research Group
Hamilton, Ontario, Canada
Start Date
September 30, 2021
Primary Completion Date
October 31, 2022
Completion Date
November 30, 2022
Last Updated
July 19, 2022
NCT07364578
NCT06488144
NCT07058623
NCT06083480
NCT06955481
NCT06208631
Lead Sponsor
Bioventus LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions